85 related articles for article (PubMed ID: 27648599)
1. Isolated Polar Amino Acid Residues Modulate Lipid Binding in the Large Hydrophobic Cavity of CD1d.
Inuki S; Aiba T; Hirata N; Ichihara O; Yoshidome D; Kita S; Maenaka K; Fukase K; Fujimoto Y
ACS Chem Biol; 2016 Nov; 11(11):3132-3139. PubMed ID: 27648599
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies of Bz amide-containing α-GalCer derivatives as natural killer T cell modulators.
Kishi J; Inuki S; Hirata N; Kashiwabara E; Yoshidome D; Ichihara O; Fujimoto Y
Bioorg Med Chem Lett; 2019 Apr; 29(8):970-973. PubMed ID: 30824201
[TBL] [Abstract][Full Text] [Related]
3. Design and Discovery of Covalent α-GalCer Derivatives as Potent CD1d Ligands.
Kishi J; Inuki S; Kashiwabara E; Suzuki T; Dohmae N; Fujimoto Y
ACS Chem Biol; 2020 Feb; 15(2):353-359. PubMed ID: 31939653
[TBL] [Abstract][Full Text] [Related]
4. A molecular switch in mouse CD1d modulates natural killer T cell activation by α-galactosylsphingamides.
Wang J; Guillaume J; Janssens J; Remesh SG; Ying G; Bitra A; Van Calenbergh S; Zajonc DM
J Biol Chem; 2019 Sep; 294(39):14345-14356. PubMed ID: 31391251
[TBL] [Abstract][Full Text] [Related]
5. Potent Th2 Cytokine Bias of Natural Killer T Cell by CD1d Glycolipid Ligands: Anchoring Effect of Polar Groups in the Lipid Component.
Inuki S; Kashiwabara E; Hirata N; Kishi J; Nabika E; Fujimoto Y
Angew Chem Int Ed Engl; 2018 Jul; 57(31):9655-9659. PubMed ID: 29863807
[TBL] [Abstract][Full Text] [Related]
6. Polar functional group-containing glycolipid CD1d ligands modulate cytokine-biasing responses and prevent experimental colitis.
Inuki S; Hirata N; Kashiwabara E; Kishi J; Aiba T; Teratani T; Nakamura W; Kojima Y; Maruyama T; Kanai T; Fujimoto Y
Sci Rep; 2020 Sep; 10(1):15766. PubMed ID: 32978421
[TBL] [Abstract][Full Text] [Related]
7. Chemical Synthesis and Molecular Interaction Analysis of α-Galactosyl Ceramide Derivatives as CD1d Ligands.
Ueki K; Sueyoshi K; Inuki S; Fujimoto Y
Methods Mol Biol; 2023; 2613():13-22. PubMed ID: 36587067
[TBL] [Abstract][Full Text] [Related]
8. Site-specific effect of polar functional group-modification in lipids of TLR2 ligands for modulating the ligand immunostimulatory activity.
Arai Y; Inuki S; Fujimoto Y
Bioorg Med Chem Lett; 2018 May; 28(9):1638-1641. PubMed ID: 29598910
[TBL] [Abstract][Full Text] [Related]
9. Species Specific Differences of CD1d Oligomer Loading In Vitro.
Paletta D; Fichtner AS; Starick L; Porcelli SA; Savage PB; Herrmann T
PLoS One; 2015; 10(11):e0143449. PubMed ID: 26599805
[TBL] [Abstract][Full Text] [Related]
10. The crystal structure of human CD1d with and without alpha-galactosylceramide.
Koch M; Stronge VS; Shepherd D; Gadola SD; Mathew B; Ritter G; Fersht AR; Besra GS; Schmidt RR; Jones EY; Cerundolo V
Nat Immunol; 2005 Aug; 6(8):819-26. PubMed ID: 16007090
[TBL] [Abstract][Full Text] [Related]
11. Computational structure activity relationship studies on the CD1d/glycolipid/TCR complex using AMBER and AUTODOCK.
Nadas J; Li C; Wang PG
J Chem Inf Model; 2009 Feb; 49(2):410-23. PubMed ID: 19434842
[TBL] [Abstract][Full Text] [Related]
12. Atypical natural killer T-cell receptor recognition of CD1d-lipid antigens.
Le Nours J; Praveena T; Pellicci DG; Gherardin NA; Ross FJ; Lim RT; Besra GS; Keshipeddy S; Richardson SK; Howell AR; Gras S; Godfrey DI; Rossjohn J; Uldrich AP
Nat Commun; 2016 Feb; 7():10570. PubMed ID: 26875526
[TBL] [Abstract][Full Text] [Related]
13. Structural Dynamics of the Lipid Antigen-Binding Site of CD1d Protein.
Cuevas-Zuviría B; Mínguez-Toral M; Díaz-Perales A; Garrido-Arandia M; Pacios LF
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32244759
[TBL] [Abstract][Full Text] [Related]
14. Design and Evaluation of ω-Hydroxy Fatty Acids Containing α-GalCer Analogues for CD1d-Mediated NKT Cell Activation.
Lim C; Kim JH; Baek DJ; Lee JY; Cho M; Lee YS; Kang CY; Chung DH; Cho WJ; Kim S
ACS Med Chem Lett; 2014 Apr; 5(4):331-5. PubMed ID: 24900836
[TBL] [Abstract][Full Text] [Related]
15. Towards multivalent CD1d ligands: synthesis and biological activity of homodimeric α-galactosyl ceramide analogues.
Jervis PJ; Moulis M; Jukes JP; Ghadbane H; Cox LR; Cerundolo V; Besra GS
Carbohydr Res; 2012 Jul; 356(9-10):152-62. PubMed ID: 22445102
[TBL] [Abstract][Full Text] [Related]
16. Structure of an α-Helical Peptide and Lipopeptide Bound to the Nonclassical Major Histocompatibility Complex (MHC) Class I Molecule CD1d.
Girardi E; Wang J; Zajonc DM
J Biol Chem; 2016 May; 291(20):10677-83. PubMed ID: 27006394
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells.
Fischer K; Scotet E; Niemeyer M; Koebernick H; Zerrahn J; Maillet S; Hurwitz R; Kursar M; Bonneville M; Kaufmann SH; Schaible UE
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10685-90. PubMed ID: 15243159
[TBL] [Abstract][Full Text] [Related]
18. The A' and F' pockets of human CD1b are both required for optimal presentation of lipid antigens to T cells.
Niazi K; Chiu M; Mendoza R; Degano M; Khurana S; Moody D; Melián A; Wilson I; Kronenberg M; Porcelli S; Modlin R
J Immunol; 2001 Feb; 166(4):2562-70. PubMed ID: 11160317
[TBL] [Abstract][Full Text] [Related]
19. A method for production of recombinant mCD1d protein in insect cells.
Khurana A; Kronenberg M
J Vis Exp; 2007; (10):556. PubMed ID: 18989404
[TBL] [Abstract][Full Text] [Related]
20. Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.
Hung JT; Huang JR; Yu AL
J Biomed Sci; 2017 Mar; 24(1):22. PubMed ID: 28335781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
